Scarica l'app Stockscreener
106.31
0.07%
0.07
Verona Pharma Plc Adr Azioni (VRNA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
35.25%
103.14
|
76.26 | 5.624 | - | - |
Operating Expenses
|
3.77%
89.83
|
86.57 | 46.29 | 68.42 | 27.20 |
| Benefits Costs and Expenses |
1.68%
91.26
|
92.81 | 48.34 | - | - |
| Costs And Expenses |
1.68%
91.26
|
92.81 | 48.34 | - | - |
| Operating Income/Loss |
228.96%
13.30
|
-10.32 | -40.67 | -68.42 | -27.20 |
| Nonoperating Income/Loss |
77.20%
-1.423
|
-6.241 | -2.045 | -1.398 | 2.158 |
| Income/Loss From Continuing Operations Before Tax |
171.76%
11.88
|
-16.56 | -42.71 | -69.82 | -25.04 |
| Income Tax Expense/Benefit |
83.68%
-0.039
|
-0.239 | 0.25 | 1.014 | 0.754 |
| Income/Loss From Continuing Operations After Tax |
173.05%
11.92
|
-16.32 | -42.96 | -70.83 | -25.79 |
|
Net Income/Loss
|
173.05%
11.92
|
-16.32 | -42.96 | -70.83 | -25.79 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.85%
685.15
|
679.40 | 651.94 | 648.22 | 645.70 |
| Diluted Average Shares |
7.04%
727.22
|
679.40 | 651.94 | 648.22 | 645.70 |
| Basic Earnings Per Share |
200.00%
0.02
|
-0.02 | -0.07 | -0.11 | -0.04 |
| Diluted Earnings Per Share |
200.00%
0.02
|
-0.02 | -0.07 | -0.11 | -0.04 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):